Harrow Health Inc
HROW NASDAQ
6.26
-0.31
-4.72%
Closed 16:00 05/21 EDT
Open
6.58
Prev Close
6.57
High
6.65
Low
6.19
Volume
299.93K
Avg Vol (3M)
236.25K
52 Week High
7.20
52 Week Low
1.990
% Turnover
1.21%
Market Cap
154.74M
1D
5D
1M
3M
1Y
5Y
Comments
No Data
Related
Amplify Online Retail ETFiShares MSCI EAFE ESG Optimized ETFMAM SoftwarePluristemWPCS IntlQuotientFirst FoundationAmeris BancorpStealthGasMDC PartnrsThe9 LtdNiceBancorpWaterstone FinlPepsiCoGladstone LandSimply Good FoodGCI LibertyPROVENTION BIO, INC.Palomar Holdings Inc
Webull offers Harrow Health Inc HROW stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.
Company Profile
Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., owns diversified portfolio of healthcare businesses. The Company’s subsidiaries are Imprimis Pharmaceuticals Inc. and Park Compounding. Imprimis Pharmaceuticals Inc. is engaged in ophthalmology pharmaceutical compounding business. Park Compounding is engaged in compounding business and also offers strategic research and development facilities, which is engaged in developing and dispensing medicines for individual patients.
MORE >Recently
Name
Price
%Change